Although the bilateral breast cancer patient (i.e., 2852) had a functional wild-type p53 protein as evidenced by the p53-dependent apoptosis, it is apparent that other genetic events possibly precipitated by the chromosomal rearrangements that have been observed are at play. The gene discussed is TP53; the disease is breast cancer.